Injection site microflora in persons with diabetes: why needle reuse is not associated with increased infections?

导出 OA

翻译打印收藏纠错

第一作者： Sofia,Wareham-Mathiassen

第一单位： Department of Immunology and Microbiology, Copenhagen University, Copenhagen, Denmark.;Department of Front-End Innovation, Devices & Delivery Solutions, Novo Nordisk A/S, Hillerød, Denmark.

作者： Sofia,Wareham-Mathiassen ^[1] ; Lene,Bay ^[2] ; Vera Pinto,Glenting ^[3] ; Naireen,Fatima ^[2] ; Henrik,Bengtsson ^[4] ; Thomas,Bjarnsholt ^[5]

作者单位： Department of Immunology and Microbiology, Copenhagen University, Copenhagen, Denmark.;Department of Front-End Innovation, Devices & Delivery Solutions, Novo Nordisk A/S, Hillerød, Denmark. ^[1] Department of Immunology and Microbiology, Copenhagen University, Copenhagen, Denmark. ^[2] Department of Packaging & Materials Development, Devices & Delivery Solutions, Novo Nordisk A/S, Hillerød, Denmark. ^[3] Department of SaMD Design control & Engineering, Novo Nordisk A/S, Søborg, Denmark. ^[4] Department of Immunology and Microbiology, Copenhagen University, Copenhagen, Denmark.;Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark. ^[5]

关键词 Injection sites insulin delivery medical devices needle reuse skin microflora

主题词糖尿病(Diabetes Mellitus);人类(Humans);注射, 皮下(Injections, Subcutaneous);胰岛素(Insulin);针(Needles);皮肤(Skin)

DOI 10.1111/apm.13230

PMID 35460122

发布时间 2022-07-31

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交